InvestorsHub Logo
Followers 243
Posts 13901
Boards Moderated 6
Alias Born 01/29/2014

Re: None

Wednesday, 09/03/2014 12:39:44 AM

Wednesday, September 03, 2014 12:39:44 AM

Post# of 1752
FROM STOCKTWITS-"...Roche, the Swiss drugmaker, might make an offer for Exelixis. The two companies have collaborated on a drug to treat advanced melanoma. Roche already has a drug, Zelboraf, whose effectiveness to block tumors increases when combined with Exelixis’ Cobimetinib."

EXEL

BOOMTOWN
IHUB's new penny buzz board.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EXEL News